Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

364 Results Found

Letter/Comment
Public

AHA Comments on Medicare Transaction Facilitator Under Medicare Drug Price Negotiation Program

AHA comments on the Centers for Medicare & Medicaid Services information collection request regarding the Medicare Transaction Facilitator (MTF) under the Medicare drug negotiation program.
Action Alert
Member

ACT NOW: Urge Your Members of Congress to Protect Medicaid and Other Crucial Programs

Congressional committees have begun marking up their portions of a reconciliation bill to enact key pieces of President Trump’s agenda.
Advisory
Member

Updated Medicare Advantage Question and Complaint Process for Provider Organizations

CMS has released an updated complaint form with instructions for Medicare providers seeking assistance from the Centers for Medicare & Medicaid Services (CMS) in resolving Medicare Advantage (MA) claims issues.
340B Advocacy Alliance Bulletin
Member

340B Advocacy Alliance Bulletin - April 24, 2025

340B Advocacy Alliance Bulletin for April 24, 2025.
340B Advocacy Alliance Bulletin
Member

AHA 340B Advocacy Alliance Bulletin - April 22, 2025

AHA 340B Advocacy Alliance Bulletin for April 22, 2025.
Letter/Comment
Public

AHA Supports House Securing Access to Care for Seniors in Critical Condition Act

April 15, 2025The Honorable Kevin HernU.S. House of Representatives171 Cannon House Office BuildingWashington, DC 20515
Landing Page
Public

The 340B Drug Pricing Program

For more than 30 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription drug costs. Despite significant oversight from HRSA and the program’s proven record of decreasing government spending and expanding access to patient care, some want to scale it back or drastically reduce the benefits that eligible hospitals and their patients receive from the program.
Fact Sheets
Public

Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements

Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities. 
340B Advocacy Alliance Bulletin
Member

AHA 340B Advocacy Alliance - April 17, 2025

The Administration releases executive order on drug pricing; read AHA’s statement.
Action Alert
Member Non-Fed

TAKE ACTION: Urge Lawmakers to Reject Medicaid Cuts, Protect Access to Care

With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.